Transparency – Reporting Transfers of Value to Healthcare Professionals
Celgene recognises that the sharing of medical and scientific knowledge amongst healthcare professionals contributes to the quality use of medicines and improves patient care. Therefore, Celgene may support healthcare professionals to participate in scientific congresses and medical education forums.
Celgene may also engage healthcare professionals to provide independent advice based on their medical knowledge and clinical expertise, to assist the drug development process and facilitate the safe and effective use of Celgene’s products.
Such support and engagement of healthcare professionals may involve the provision of reportable payments (transfers of value) from Celgene to Australian healthcare professionals.
As a member of Medicines Australia, Celgene Pty Ltd has undertaken to be transparent when providing a reportable payment to a healthcare professional. Reportable payments are:
- Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an advisory board, or as a consultant
- Airfares, accommodation and/or conference registration fees to attend medical education and/or as part of the provision of services.
Celgene has prepared the Transparency report in accordance with the Medicines Australia Code of Conduct and Australia’s privacy legislation. The report identifies healthcare professionals by name where their consent has been provided. Where consent has not been provided the information is reported in aggregate.
From 1 October 2016, reporting of these payments is mandatory, and healthcare professionals should reasonably expect that all reportable payments occurring on or after that date will be disclosed, including the name and other required details of the healthcare professional.
The Transparency report is designed to be read on this website. It is also provided as a downloadable CSV file.
To comply with privacy obligations, the report may be amended from time to time. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.
The Celgene transparency reports are available below. Reports will remain available for three years from the date of publication.
From 30 August 2019, the information for reporting period 01 November 2018 to 30 April 2019 and subsequent reporting periods is held in a database, administered by Medicines Australia. This database is designed to be searchable as well as downloaded as a CSV file. For further information about the details in the reports, or to search the database, please visit www.DisclosureAustralia.com.au.